Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 171 entries
Sorted by: Best Match Show Resources per page
14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency.

Frontiers in immunology

Schepp J, Chou J, Skrabl-Baumgartner A, Arkwright PD, Engelhardt KR, Hambleton S, Morio T, Röther E, Warnatz K, Geha R, Grimbacher B.
PMID: 28861081
Front Immunol. 2017 Aug 16;8:964. doi: 10.3389/fimmu.2017.00964. eCollection 2017.

BACKGROUND: Inducible co-stimulator (ICOS) deficiency was the first monogenic defect reported to cause common variable immunodeficiency (CVID)-like disease in 2003. Since then, 16 patients have been reported worldwide with an increasing range of clinical phenotypes.OBJECTIVE: We sought to compare...

Cite
Schepp J, Chou J, Skrabl-Baumgartner A, et al. 14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency. Front Immunol. 2017;8:964doi: 10.3389/fimmu.2017.00964.
Schepp, J., Chou, J., Skrabl-Baumgartner, A., Arkwright, P. D., Engelhardt, K. R., Hambleton, S., Morio, T., Röther, E., Warnatz, K., Geha, R., & Grimbacher, B. (2017). 14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency. Frontiers in immunology, 8964. https://doi.org/10.3389/fimmu.2017.00964
Schepp, Johanna, et al. "14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency." Frontiers in immunology vol. 8 (2017): 964. doi: https://doi.org/10.3389/fimmu.2017.00964
Schepp J, Chou J, Skrabl-Baumgartner A, Arkwright PD, Engelhardt KR, Hambleton S, Morio T, Röther E, Warnatz K, Geha R, Grimbacher B. 14 Years after Discovery: Clinical Follow-up on 15 Patients with Inducible Co-Stimulator Deficiency. Front Immunol. 2017 Aug 16;8:964. doi: 10.3389/fimmu.2017.00964. eCollection 2017. PMID: 28861081; PMCID: PMC5561331.
Copy Download .nbib Format: NLM
Primary producers sustaining macro-invertebrate communities in intertidal mangrove forests.

Oecologia

Bouillon S, Koedam N, Raman A, Dehairs F.
PMID: 28547052
Oecologia. 2002 Feb;130(3):441-448. doi: 10.1007/s004420100814. Epub 2002 Feb 01.

In contrast to the large number of studies on the trophic significance of mangrove primary production to the aquatic foodweb, there have been few attempts to provide an overview of the relative importance of different primary carbon sources to...

Cite
Bouillon S, Koedam N, Raman A, et al. Primary producers sustaining macro-invertebrate communities in intertidal mangrove forests. Oecologia. 2002;130(3):441-448doi: 10.1007/s004420100814.
Bouillon, S., Koedam, N., Raman, A., & Dehairs, F. (2002). Primary producers sustaining macro-invertebrate communities in intertidal mangrove forests. Oecologia, 130(3), 441-448. https://doi.org/10.1007/s004420100814
Bouillon, S, et al. "Primary producers sustaining macro-invertebrate communities in intertidal mangrove forests." Oecologia vol. 130,3 (2002): 441-448. doi: https://doi.org/10.1007/s004420100814
Bouillon S, Koedam N, Raman A, Dehairs F. Primary producers sustaining macro-invertebrate communities in intertidal mangrove forests. Oecologia. 2002 Feb;130(3):441-448. doi: 10.1007/s004420100814. Epub 2002 Feb 01. PMID: 28547052.
Copy Download .nbib Format: NLM
Increased temperature, but not acidification, enhances fertilization and development in a tropical urchin: potential for adaptation to a tropicalized eastern Australia.

Evolutionary applications

Foo SA, Dworjanyn SA, Khatkar MS, Poore AG, Byrne M.
PMID: 25558283
Evol Appl. 2014 Dec;7(10):1226-37. doi: 10.1111/eva.12218. Epub 2014 Oct 15.

To predict the effects of global change on marine populations, it is important to measure the effects of climate stressors on performance and potential for adaptation. Adaptation depends on heritable genetic variance for stress tolerance being present in populations....

Cite
Foo SA, Dworjanyn SA, Khatkar MS, et al. Increased temperature, but not acidification, enhances fertilization and development in a tropical urchin: potential for adaptation to a tropicalized eastern Australia. Evol Appl. 2014;7(10):1226-37doi: 10.1111/eva.12218.
Foo, S. A., Dworjanyn, S. A., Khatkar, M. S., Poore, A. G., & Byrne, M. (2014). Increased temperature, but not acidification, enhances fertilization and development in a tropical urchin: potential for adaptation to a tropicalized eastern Australia. Evolutionary applications, 7(10), 1226-37. https://doi.org/10.1111/eva.12218
Foo, Shawna A, et al. "Increased temperature, but not acidification, enhances fertilization and development in a tropical urchin: potential for adaptation to a tropicalized eastern Australia." Evolutionary applications vol. 7,10 (2014): 1226-37. doi: https://doi.org/10.1111/eva.12218
Foo SA, Dworjanyn SA, Khatkar MS, Poore AG, Byrne M. Increased temperature, but not acidification, enhances fertilization and development in a tropical urchin: potential for adaptation to a tropicalized eastern Australia. Evol Appl. 2014 Dec;7(10):1226-37. doi: 10.1111/eva.12218. Epub 2014 Oct 15. PMID: 25558283; PMCID: PMC4275094.
Copy Download .nbib Format: NLM
Fluoroscopy guided percutaneous renal access in prone position.

World journal of clinical cases

Sharma GR, Maheshwari PN, Sharma AG, Maheshwari RP, Heda RS, Maheshwari SP.
PMID: 25789297
World J Clin Cases. 2015 Mar 16;3(3):245-64. doi: 10.12998/wjcc.v3.i3.245.

Percutaneous nephrolithotomy is a very commonly done procedure for management of renal calculus disease. Establishing a good access is the first and probably the most crucial step of this procedure. A proper access is the gateway to success. However,...

Cite
Sharma GR, Maheshwari PN, Sharma AG, et al. Fluoroscopy guided percutaneous renal access in prone position. World J Clin Cases. 2015;3(3):245-64doi: 10.12998/wjcc.v3.i3.245.
Sharma, G. R., Maheshwari, P. N., Sharma, A. G., Maheshwari, R. P., Heda, R. S., & Maheshwari, S. P. (2015). Fluoroscopy guided percutaneous renal access in prone position. World journal of clinical cases, 3(3), 245-64. https://doi.org/10.12998/wjcc.v3.i3.245
Sharma, Gyanendra R, et al. "Fluoroscopy guided percutaneous renal access in prone position." World journal of clinical cases vol. 3,3 (2015): 245-64. doi: https://doi.org/10.12998/wjcc.v3.i3.245
Sharma GR, Maheshwari PN, Sharma AG, Maheshwari RP, Heda RS, Maheshwari SP. Fluoroscopy guided percutaneous renal access in prone position. World J Clin Cases. 2015 Mar 16;3(3):245-64. doi: 10.12998/wjcc.v3.i3.245. PMID: 25789297; PMCID: PMC4360496.
Copy Download .nbib Format: NLM
[Assessment of ECG depolarization changes--diagnostic challenge].

Harefuah

Behar S, Neufeld HN.
PMID: 3804077
Harefuah. 1986 Oct;111(7):206-7.

No abstract available.

Cite
Behar S, Neufeld HN. [Assessment of ECG depolarization changes--diagnostic challenge]. Harefuah. 1986;111(7):206-7
Behar, S., & Neufeld, H. N. (1986). [Assessment of ECG depolarization changes--diagnostic challenge]. Harefuah, 111(7), 206-7.
Behar, S, and Neufeld, H N. "[Assessment of ECG depolarization changes--diagnostic challenge]." Harefuah vol. 111,7 (1986): 206-7.
Behar S, Neufeld HN. [Assessment of ECG depolarization changes--diagnostic challenge]. Harefuah. 1986 Oct;111(7):206-7. Hebrew. PMID: 3804077.
Copy Download .nbib Format: NLM
Reply to Narra.

The Journal of allergy and clinical immunology

Ozcan E, Geha RS, Notarangelo LD.
PMID: 20706548
J Allergy Clin Immunol. 2009 Jun 01;123(6):1419-1420. doi: 10.1016/j.jaci.2009.03.009.

No abstract available.

Cite
Ozcan E, Geha RS, Notarangelo LD. Reply to Narra. J Allergy Clin Immunol. 2009;123(6):1419-1420doi: 10.1016/j.jaci.2009.03.009.
Ozcan, E., Geha, R. S., & Notarangelo, L. D. (2009). Reply to Narra. The Journal of allergy and clinical immunology, 123(6), 1419-1420. https://doi.org/10.1016/j.jaci.2009.03.009
Ozcan, Esra, et al. "Reply to Narra." The Journal of allergy and clinical immunology vol. 123,6 (2009): 1419-1420. doi: https://doi.org/10.1016/j.jaci.2009.03.009
Ozcan E, Geha RS, Notarangelo LD. Reply to Narra. J Allergy Clin Immunol. 2009 Jun 01;123(6):1419-1420. doi: 10.1016/j.jaci.2009.03.009. PMID: 20706548; PMCID: PMC2919770.
Copy Download .nbib Format: NLM
Synthesis of Functionalized Cyclopropanes from Carboxylic Acids by a Radical Addition-Polar Cyclization Cascade.

Angewandte Chemie (International ed. in English)

Shu C, Mega RS, Andreassen BJ, Noble A, Aggarwal VK.
PMID: 30204292
Angew Chem Int Ed Engl. 2018 Nov 19;57(47):15430-15434. doi: 10.1002/anie.201808598. Epub 2018 Oct 25.

Herein, we describe the development of a photoredox-catalyzed decarboxylative radical addition-polar cyclization cascade approach to functionalized cyclopropanes. Reductive termination of radical-polar crossover reactions between aliphatic carboxylic acids and electron-deficient alkenes yielded carbanion intermediates that were intercepted in intramolecular alkylations...

Cite
Shu C, Mega RS, Andreassen BJ, et al. Synthesis of Functionalized Cyclopropanes from Carboxylic Acids by a Radical Addition-Polar Cyclization Cascade. Angew Chem Int Ed Engl. 2018;57(47):15430-15434doi: 10.1002/anie.201808598.
Shu, C., Mega, R. S., Andreassen, B. J., Noble, A., & Aggarwal, V. K. (2018). Synthesis of Functionalized Cyclopropanes from Carboxylic Acids by a Radical Addition-Polar Cyclization Cascade. Angewandte Chemie (International ed. in English), 57(47), 15430-15434. https://doi.org/10.1002/anie.201808598
Shu, Chao, et al. "Synthesis of Functionalized Cyclopropanes from Carboxylic Acids by a Radical Addition-Polar Cyclization Cascade." Angewandte Chemie (International ed. in English) vol. 57,47 (2018): 15430-15434. doi: https://doi.org/10.1002/anie.201808598
Shu C, Mega RS, Andreassen BJ, Noble A, Aggarwal VK. Synthesis of Functionalized Cyclopropanes from Carboxylic Acids by a Radical Addition-Polar Cyclization Cascade. Angew Chem Int Ed Engl. 2018 Nov 19;57(47):15430-15434. doi: 10.1002/anie.201808598. Epub 2018 Oct 25. PMID: 30204292; PMCID: PMC6282618.
Copy Download .nbib Format: NLM
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56.

Frontiers in immunology

Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, Al-Herz W, Cancrini C, Cowan M, Bleesing J, Booth C, Buchbinder D, Burns SO, Chatila TA, Chou J, Daza-Cajigal V, Ott de Bruin LM, de la Morena M, Di Matteo G, Finocchi A, Geha R, Goyal RK, Hayward A, Holland S, Huang CH, Kanariou MG, King A, Kaplan B, Kleva A, Kuijpers TW, Lee BW, Lougaris V, Massaad M, Meyts I, Morsheimer M, Neven B, Pai SY, Parvaneh N, Plebani A, Prockop S, Reisli I, Soh JY, Somech R, Torgerson TR, Kim YJ, Walter JE, Gennery AR, Keles S, Manis JP, Marcenaro E, Moretta A, Parolini S, Notarangelo LD.
PMID: 28769923
Front Immunol. 2017 Jul 17;8:798. doi: 10.3389/fimmu.2017.00798. eCollection 2017.

Mutations of the recombinase-activating genes 1 and 2 (

Cite
Dobbs K, Tabellini G, Calzoni E, et al. Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56. Front Immunol. 2017;8:798doi: 10.3389/fimmu.2017.00798.
Dobbs, K., Tabellini, G., Calzoni, E., Patrizi, O., Martinez, P., Giliani, S. C., Moratto, D., Al-Herz, W., Cancrini, C., Cowan, M., Bleesing, J., Booth, C., Buchbinder, D., Burns, S. O., Chatila, T. A., Chou, J., Daza-Cajigal, V., Ott de Bruin, L. M., de la Morena, M., Di Matteo, G., Finocchi, A., Geha, R., Goyal, R. K., Hayward, A., Holland, S., Huang, C. H., Kanariou, M. G., King, A., Kaplan, B., Kleva, A., Kuijpers, T. W., Lee, B. W., Lougaris, V., Massaad, M., Meyts, I., Morsheimer, M., Neven, B., Pai, S. Y., Parvaneh, N., Plebani, A., Prockop, S., Reisli, I., Soh, J. Y., Somech, R., Torgerson, T. R., Kim, Y. J., Walter, J. E., Gennery, A. R., Keles, S., Manis, J. P., Marcenaro, E., Moretta, A., Parolini, S., & Notarangelo, L. D. (2017). Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56. Frontiers in immunology, 8798. https://doi.org/10.3389/fimmu.2017.00798
Dobbs, Kerry, et al. "Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56." Frontiers in immunology vol. 8 (2017): 798. doi: https://doi.org/10.3389/fimmu.2017.00798
Dobbs K, Tabellini G, Calzoni E, Patrizi O, Martinez P, Giliani SC, Moratto D, Al-Herz W, Cancrini C, Cowan M, Bleesing J, Booth C, Buchbinder D, Burns SO, Chatila TA, Chou J, Daza-Cajigal V, Ott de Bruin LM, de la Morena M, Di Matteo G, Finocchi A, Geha R, Goyal RK, Hayward A, Holland S, Huang CH, Kanariou MG, King A, Kaplan B, Kleva A, Kuijpers TW, Lee BW, Lougaris V, Massaad M, Meyts I, Morsheimer M, Neven B, Pai SY, Parvaneh N, Plebani A, Prockop S, Reisli I, Soh JY, Somech R, Torgerson TR, Kim YJ, Walter JE, Gennery AR, Keles S, Manis JP, Marcenaro E, Moretta A, Parolini S, Notarangelo LD. Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56. Front Immunol. 2017 Jul 17;8:798. doi: 10.3389/fimmu.2017.00798. eCollection 2017. PMID: 28769923; PMCID: PMC5511964.
Copy Download .nbib Format: NLM
Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study.

Cardiology and therapy

Ballantyne CM, Manku MS, Bays HE, Philip S, Granowitz C, Doyle RT, Juliano RA.
PMID: 30788718
Cardiol Ther. 2019 Jun;8(1):79-90. doi: 10.1007/s40119-019-0131-8. Epub 2019 Feb 20.

INTRODUCTION: Fatty acid content in plasma and red blood cells (RBCs) may provide insight into potential physiologic benefits of omega-3 fatty acids. Icosapent ethyl is a pure prescription form of eicosapentaenoic acid (EPA) ethyl ester approved by the US...

Cite
Ballantyne CM, Manku MS, Bays HE, et al. Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study. Cardiol Ther. 2019;8(1):79-90doi: 10.1007/s40119-019-0131-8.
Ballantyne, C. M., Manku, M. S., Bays, H. E., Philip, S., Granowitz, C., Doyle, R. T., & Juliano, R. A. (2019). Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study. Cardiology and therapy, 8(1), 79-90. https://doi.org/10.1007/s40119-019-0131-8
Ballantyne, Christie M, et al. "Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study." Cardiology and therapy vol. 8,1 (2019): 79-90. doi: https://doi.org/10.1007/s40119-019-0131-8
Ballantyne CM, Manku MS, Bays HE, Philip S, Granowitz C, Doyle RT, Juliano RA. Icosapent Ethyl Effects on Fatty Acid Profiles in Statin-Treated Patients With High Triglycerides: The Randomized, Placebo-controlled ANCHOR Study. Cardiol Ther. 2019 Jun;8(1):79-90. doi: 10.1007/s40119-019-0131-8. Epub 2019 Feb 20. PMID: 30788718; PMCID: PMC6525216.
Copy Download .nbib Format: NLM
The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature.

Clinical proteomics

Chauvin A, Wang CS, Geha S, Garde-Granger P, Mathieu AA, Lacasse V, Boisvert FM.
PMID: 29681787
Clin Proteomics. 2018 Apr 13;15:16. doi: 10.1186/s12014-018-9192-2. eCollection 2018.

BACKGROUND: Colorectal cancer is the third most common and the fourth most lethal cancer in the world. In the majority of cases, patients are diagnosed at an advanced stage or even metastatic, thus explaining the high mortality. The standard...

Cite
Chauvin A, Wang CS, Geha S, et al. The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature. Clin Proteomics. 2018;15:16doi: 10.1186/s12014-018-9192-2.
Chauvin, A., Wang, C. S., Geha, S., Garde-Granger, P., Mathieu, A. A., Lacasse, V., & Boisvert, F. M. (2018). The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature. Clinical proteomics, 1516. https://doi.org/10.1186/s12014-018-9192-2
Chauvin, Anaïs, et al. "The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature." Clinical proteomics vol. 15 (2018): 16. doi: https://doi.org/10.1186/s12014-018-9192-2
Chauvin A, Wang CS, Geha S, Garde-Granger P, Mathieu AA, Lacasse V, Boisvert FM. The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature. Clin Proteomics. 2018 Apr 13;15:16. doi: 10.1186/s12014-018-9192-2. eCollection 2018. PMID: 29681787; PMCID: PMC5898006.
Copy Download .nbib Format: NLM
Advanced heart failure with reduced ejection fraction.

Proceedings (Baylor University. Medical Center)

Hicks A, Velazco JF, Gohar S, Seliem A, Hall SA, Michel JB.
PMID: 32675952
Proc (Bayl Univ Med Cent). 2020 Jun 02;33(3):350-356. doi: 10.1080/08998280.2020.1765663. eCollection 2020 Jul.

Patients suffering advanced heart failure with reduced ejection fraction (HFrEF) account for a large portion of patients admitted to hospitals worldwide. Mortality and 30-day readmission rates for HFrEF are now a focus of value-based payment models, making management of...

Cite
Hicks A, Velazco JF, Gohar S, et al. Advanced heart failure with reduced ejection fraction. Proc (Bayl Univ Med Cent). 2020;33(3):350-356doi: 10.1080/08998280.2020.1765663.
Hicks, A., Velazco, J. F., Gohar, S., Seliem, A., Hall, S. A., & Michel, J. B. (2020). Advanced heart failure with reduced ejection fraction. Proceedings (Baylor University. Medical Center), 33(3), 350-356. https://doi.org/10.1080/08998280.2020.1765663
Hicks, Albert, et al. "Advanced heart failure with reduced ejection fraction." Proceedings (Baylor University. Medical Center) vol. 33,3 (2020): 350-356. doi: https://doi.org/10.1080/08998280.2020.1765663
Hicks A, Velazco JF, Gohar S, Seliem A, Hall SA, Michel JB. Advanced heart failure with reduced ejection fraction. Proc (Bayl Univ Med Cent). 2020 Jun 02;33(3):350-356. doi: 10.1080/08998280.2020.1765663. eCollection 2020 Jul. PMID: 32675952; PMCID: PMC7340451.
Copy Download .nbib Format: NLM
The Acute Effect of Exercise on Executive Function and Attention: Resistance Versus Aerobic Exercise.

Advances in cognitive psychology

Tsuk S, Netz Y, Dunsky A, Zeev A, Carasso R, Dwolatzky T, Salem R, Behar S, Rotstein A.
PMID: 32161629
Adv Cogn Psychol. 2019 Sep 03;15(3):208-215. doi: 10.5709/acp-0269-7. eCollection 2019.

Acute aerobic exercise was shown to enhance such cognitive functions as executive function (EF) and attention. Acute resistance exercise was also shown to enhance cognitive functions, however, only few studies directly compared these two exercise modalities. The aim of...

Cite
Tsuk S, Netz Y, Dunsky A, et al. The Acute Effect of Exercise on Executive Function and Attention: Resistance Versus Aerobic Exercise. Adv Cogn Psychol. 2019;15(3):208-215doi: 10.5709/acp-0269-7.
Tsuk, S., Netz, Y., Dunsky, A., Zeev, A., Carasso, R., Dwolatzky, T., Salem, R., Behar, S., & Rotstein, A. (2019). The Acute Effect of Exercise on Executive Function and Attention: Resistance Versus Aerobic Exercise. Advances in cognitive psychology, 15(3), 208-215. https://doi.org/10.5709/acp-0269-7
Tsuk, Sharon, et al. "The Acute Effect of Exercise on Executive Function and Attention: Resistance Versus Aerobic Exercise." Advances in cognitive psychology vol. 15,3 (2019): 208-215. doi: https://doi.org/10.5709/acp-0269-7
Tsuk S, Netz Y, Dunsky A, Zeev A, Carasso R, Dwolatzky T, Salem R, Behar S, Rotstein A. The Acute Effect of Exercise on Executive Function and Attention: Resistance Versus Aerobic Exercise. Adv Cogn Psychol. 2019 Sep 03;15(3):208-215. doi: 10.5709/acp-0269-7. eCollection 2019. PMID: 32161629; PMCID: PMC6776756.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 171 entries